{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:21:40Z","timestamp":1793128900273,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":3247,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s13311-014-0300-3","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T09:19:36Z","timestamp":1409217576000},"page":"773-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Triadopathies: An Emerging Class of Skeletal Muscle Diseases"],"prefix":"10.1016","volume":"11","author":[{"given":"James J.","family":"Dowling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Dirksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-014-0300-3_bib1","series-title":"Myology: basic and clinical","author":"Engel","year":"2004"},{"key":"10.1007\/s13311-014-0300-3_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0304-4157(94)00014-5","article-title":"The role of Ca2+ ions in excitation-contraction coupling of skeletal muscle fibres","volume":"1241","author":"Melzer","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-014-0300-3_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mus.20512","article-title":"Sarcoplasmic reticulum: the dynamic calcium governor of muscle","volume":"33","author":"Rossi","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1007\/s13311-014-0300-3_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11910-012-0255-x","article-title":"Congenital myopathies: an update","volume":"12","author":"Nance","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1007\/s13311-014-0300-3_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1007\/s13311-014-0300-3_bib6","series-title":"GeneReviews\u00ae [Internet]","article-title":"Malignant hyperthermia susceptibility","author":"Rosenberg","year":"1993"},{"key":"10.1007\/s13311-014-0300-3_bib7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(98)03078-5","article-title":"Malignant hyperthermia","volume":"352","author":"Denborough","year":"1998","journal-title":"Lancet"},{"key":"10.1007\/s13311-014-0300-3_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00044067-200404000-00009","article-title":"Malignant hyperthermia: pathophysiology, clinical presentation, and treatment","volume":"15","author":"McCarthy","year":"2004","journal-title":"AACN Clin Issues"},{"key":"10.1007\/s13311-014-0300-3_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","article-title":"Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006","volume":"110","author":"Larach","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1007\/s13311-014-0300-3_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0001-2092(07)70404-0","article-title":"Malignant hyperthermia. Epidemiology, pathophysiology, treatment","volume":"59","author":"Donnelly","year":"1994","journal-title":"AORN J"},{"key":"10.1007\/s13311-014-0300-3_bib11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/ALN.0b013e3182a8a8e7","article-title":"Using exome data to identify malignant hyperthermia susceptibility mutations","volume":"119","author":"Gonsalves","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1007\/s13311-014-0300-3_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1213\/ANE.0000000000000063","article-title":"DNA testing for malignant hyperthermia: the reality and the dream","volume":"118","author":"Stowell","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1007\/s13311-014-0300-3_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1007\/s13311-014-0300-3_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2350-10-104","article-title":"The role of CACNA1S in predisposition to malignant hyperthermia","volume":"10","author":"Carpenter","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1007\/s13311-014-0300-3_bib15","series-title":"Pathologies of calcium channels","article-title":"Cav1.1 in malignant hyperthermia","author":"Yarotskyy","year":"2014"},{"key":"10.1007\/s13311-014-0300-3_bib16","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e3182a8a998","article-title":"Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families","volume":"119","author":"Kim","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1007\/s13311-014-0300-3_bib17","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1213\/ane.0b013e3181a9d8d9","article-title":"The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia","volume":"109","author":"Capacchione","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1007\/s13311-014-0300-3_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jama.286.2.168","article-title":"Malignant hyperthermia and apparent heat stroke","volume":"286","author":"Tobin","year":"2001","journal-title":"JAMA"},{"key":"10.1007\/s13311-014-0300-3_bib19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","article-title":"Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis","volume":"23","author":"Dlamini","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1007\/s13311-014-0300-3_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nmd.2011.12.003","article-title":"182nd ENMC International Workshop: RYR1-related myopathies, 15\u201317th April 2011, Naarden, The Netherlands","volume":"22","author":"Jungbluth","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1007\/s13311-014-0300-3_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-2-25","article-title":"Central core disease","volume":"2","author":"Jungbluth","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1007\/s13311-014-0300-3_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-2-31","article-title":"Multi-minicore disease","volume":"2","author":"Jungbluth","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1007\/s13311-014-0300-3_bib23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.22119","article-title":"RYR1 mutations are a common cause of congenital myopathies with central nuclei","volume":"68","author":"Wilmshurst","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-014-0300-3_bib24","doi-asserted-by":"crossref","first-page":"E1544","DOI":"10.1002\/humu.21278","article-title":"Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion","volume":"31","author":"Clarke","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1007\/s13311-014-0300-3_bib25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/humu.22056","article-title":"Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies","volume":"33","author":"Klein","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1007\/s13311-014-0300-3_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.nmd.2009.12.005","article-title":"Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"20","author":"Zhou","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1007\/s13311-014-0300-3_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.nmd.2014.05.003","article-title":"RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine","volume":"24","author":"Illingworth","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1007\/s13311-014-0300-3_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.nmd.2011.03.006","article-title":"King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"21","author":"Dowling","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1007\/s13311-014-0300-3_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.nmd.2009.02.005","article-title":"Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"19","author":"Jungbluth","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1007\/s13311-014-0300-3_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1750-1172-8-117","article-title":"Genotype-phenotype correlations in recessive RYR1-related myopathies","volume":"8","author":"Amburgey","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1007\/s13311-014-0300-3_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","article-title":"Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm","volume":"8","author":"Treves","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1007\/s13311-014-0300-3_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-2004-821173","article-title":"Pilot trial of salbutamol in central core and multi-minicore diseases","volume":"35","author":"Messina","year":"2004","journal-title":"Neuropediatrics"},{"key":"10.1007\/s13311-014-0300-3_bib33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/aws036","article-title":"Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy","volume":"135","author":"Dowling","year":"2012","journal-title":"Brain"},{"key":"10.1007\/s13311-014-0300-3_bib34","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.ddmec.2010.09.009","article-title":"Fixing ryanodine receptor Ca leak \u2013 a novel therapeutic strategy for contractile failure in heart and skeletal muscle","volume":"7","author":"Andersson","year":"2010","journal-title":"Drug Discov Today Dis Mechan"},{"key":"10.1007\/s13311-014-0300-3_bib35","doi-asserted-by":"crossref","first-page":"e49757","DOI":"10.1371\/journal.pone.0049757","article-title":"Allele-specific gene silencing in two mouse models of autosomal dominant skeletal myopathy","volume":"7","author":"Loy","year":"2012","journal-title":"PloS One"},{"key":"10.1007\/s13311-014-0300-3_bib36","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.22510","article-title":"Prevalence of congenital myopathies in a representative pediatric united states population","volume":"70","author":"Amburgey","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-014-0300-3_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nmd.2013.01.004","article-title":"Congenital myopathies\u2013clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom","volume":"23","author":"Maggi","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1007\/s13311-014-0300-3_bib38","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1073\/pnas.92.8.3381","article-title":"Abnormal junctions between surface membrane and sarcoplasmic reticulum in skeletal muscle with a mutation targeted to the ryanodine receptor","volume":"92","author":"Takekura","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-014-0300-3_bib39","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1242\/dev.004531","article-title":"Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease","volume":"134","author":"Hirata","year":"2007","journal-title":"Development"},{"key":"10.1007\/s13311-014-0300-3_bib40","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.febslet.2010.03.005","article-title":"Ryanodine receptor studies using genetically engineered mice","volume":"584","author":"Kushnir","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1007\/s13311-014-0300-3_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-3-26","article-title":"Centronuclear (myotubular) myopathy","volume":"3","author":"Jungbluth","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1007\/s13311-014-0300-3_bib42","first-page":"20","article-title":"Clinical utility gene card for: Centronuclear and myotubular myopathies","author":"Biancalana","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1007\/s13311-014-0300-3_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng0696-175","article-title":"A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast","volume":"13","author":"Laporte","year":"1996","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-014-0300-3_bib44","series-title":"GeneReviews\u00ae [Internet]","article-title":"X-linked centronuclear myopathy","author":"Das","year":"1993"},{"key":"10.1007\/s13311-014-0300-3_bib45","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ng1657","article-title":"Mutations in dynamin 2 cause dominant centronuclear myopathy","volume":"37","author":"Bitoun","year":"2005","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-014-0300-3_bib46","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/humu.22067","article-title":"Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy","volume":"33","author":"Bohm","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1007\/s13311-014-0300-3_bib47","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng2086","article-title":"Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy","volume":"39","author":"Nicot","year":"2007","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-014-0300-3_bib48","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/WNL.0b013e3182a6ca62","article-title":"Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy","volume":"81","author":"Ceyhan-Birsoy","year":"2013","journal-title":"Neurology"},{"key":"10.1007\/s13311-014-0300-3_bib49","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1212\/WNL.0b013e3182a6cc43","article-title":"Titin and centronuclear myopathy: The tip of the iceberg for TTN-ic mutations?","volume":"81","author":"Dowling","year":"2013","journal-title":"Neurology"},{"key":"10.1007\/s13311-014-0300-3_bib50","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00109-009-0587-4","article-title":"Dynamin 2 and human diseases","volume":"88","author":"Durieux","year":"2010","journal-title":"J Mol Med"},{"key":"10.1007\/s13311-014-0300-3_bib51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ejhg.2012.226","article-title":"Dynamin 2 homozygous mutation in humans with a lethal congenital syndrome","volume":"21","author":"Koutsopoulos","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1007\/s13311-014-0300-3_bib52","doi-asserted-by":"crossref","first-page":"e1000372","DOI":"10.1371\/journal.pgen.1000372","article-title":"Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy","volume":"5","author":"Dowling","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1007\/s13311-014-0300-3_bib53","doi-asserted-by":"crossref","first-page":"18763","DOI":"10.1073\/pnas.0900705106","article-title":"T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase","volume":"106","author":"Al-Qusairi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-014-0300-3_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00401-010-0754-2","article-title":"Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies","volume":"121","author":"Toussaint","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-014-0300-3_bib55","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1093\/hmg\/ddq413","article-title":"A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice","volume":"19","author":"Durieux","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-014-0300-3_bib56","first-page":"157","article-title":"The myopathy-causing mutation DNM2-S619L leads to defective tubulation in vitro and in developing zebrafish","volume":"7","author":"Gibbs","year":"2014","journal-title":"Dis Models Mechan"},{"key":"10.1007\/s13311-014-0300-3_bib57","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1093\/hmg\/ddu067","article-title":"Bridging integrator 1 (Bin1) deficiency in zebrafish results in centronuclear myopathy","volume":"23","author":"Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-014-0300-3_bib58","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.1071362","article-title":"Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle","volume":"297","author":"Lee","year":"2002","journal-title":"Science"},{"key":"10.1007\/s13311-014-0300-3_bib59","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1096\/fj.12-220947","article-title":"Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways","volume":"27","author":"Al-Qusairi","year":"2013","journal-title":"FASEB J"},{"key":"10.1007\/s13311-014-0300-3_bib60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/MCB.01075-12","article-title":"Defective autophagy and mTORC1 signaling in myotubularin null mice","volume":"33","author":"Fetalvero","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1007\/s13311-014-0300-3_bib61","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI44021","article-title":"Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle","volume":"121","author":"Hnia","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-014-0300-3_bib62","first-page":"852","article-title":"Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models","volume":"5","author":"Dowling","year":"2012","journal-title":"Dis Models Mechan"},{"key":"10.1007\/s13311-014-0300-3_bib63","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nmd.2011.02.012","article-title":"Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies","volume":"21","author":"Robb","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1007\/s13311-014-0300-3_bib64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/scitranslmed.3007523","article-title":"Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy","volume":"6","author":"Childers","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1007\/s13311-014-0300-3_bib65","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/hmg\/ddt003","article-title":"Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy","volume":"22","author":"Lawlor","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-014-0300-3_bib66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00109-013-0994-4","article-title":"Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy","volume":"91","author":"Gibbs","year":"2013","journal-title":"J Mol Med"},{"key":"10.1007\/s13311-014-0300-3_bib67","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/ajmg.a.32370","article-title":"Native American myopathy: congenital myopathy with cleft palate, skeletal anomalies, and susceptibility to malignant hyperthermia","volume":"146A","author":"Stamm","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1007\/s13311-014-0300-3_bib68","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/ncomms2952","article-title":"Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy","volume":"4","author":"Horstick","year":"2013","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-014-0300-3_bib69","doi-asserted-by":"crossref","first-page":"11881","DOI":"10.1073\/pnas.1310571110","article-title":"Skeletal muscle-specific T-tubule protein STAC3 mediates voltage-induced Ca2+ release and contractility","volume":"110","author":"Nelson","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-014-0300-3_bib70","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jocn.2007.11.010","article-title":"Tubular aggregate myopathy: a rare form of myopathy","volume":"15","author":"Jain","year":"2008","journal-title":"J Clin Neurosci"},{"key":"10.1007\/s13311-014-0300-3_bib71","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/humu.22544","article-title":"A dominant STIM1 mutation causes Stormorken syndrome","volume":"35","author":"Misceo","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1007\/s13311-014-0300-3_bib72","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1073\/pnas.1312520111","article-title":"Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis","volume":"111","author":"Nesin","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-014-0300-3_bib73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ajhg.2012.12.007","article-title":"Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy","volume":"92","author":"Bohm","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s13311-014-0300-3_bib74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-065X.2009.00818.x","article-title":"ORAI1 and STIM1 deficiency in human and mice: roles of store-operated Ca2+ entry in the immune system and beyond","volume":"231","author":"Feske","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1007\/s13311-014-0300-3_bib75","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1113\/jphysiol.2009.172148","article-title":"Checking your SOCCs and feet: the molecular mechanisms of Ca2+ entry in skeletal muscle","volume":"587","author":"Dirksen","year":"2009","journal-title":"J Physiol"},{"key":"10.1007\/s13311-014-0300-3_bib76","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1038\/ncomms3963","article-title":"STIM1\/Orai1 coiled-coil interplay in the regulation of store-operated calcium entry","volume":"4","author":"Stathopulos","year":"2013","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-014-0300-3_bib77","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/ncomms3805","article-title":"Orai1-dependent calcium entry promotes skeletal muscle growth and limits fatigue","volume":"4","author":"Wei-Lapierre","year":"2013","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-014-0300-3_bib78","doi-asserted-by":"crossref","first-page":"e77633","DOI":"10.1371\/journal.pone.0077633","article-title":"Accelerated activation of SOCE current in myotubes from two mouse models of anesthetic- and heat-induced sudden death","volume":"8","author":"Yarotskyy","year":"2013","journal-title":"PloS One"},{"key":"10.1007\/s13311-014-0300-3_bib79","doi-asserted-by":"crossref","first-page":"25645","DOI":"10.1074\/jbc.M110.104976","article-title":"Store-operated Ca2+ entry in malignant hyperthermia-susceptible human skeletal muscle","volume":"285","author":"Duke","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-014-0300-3_bib80","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00019052-199810000-00005","article-title":"Tubular aggregates in skeletal muscle: their functional significance and mechanisms of pathogenesis","volume":"11","author":"Morgan-Hughes","year":"1998","journal-title":"Curr Opin Neurol"},{"key":"10.1007\/s13311-014-0300-3_bib81","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11357-011-9211-y","article-title":"Sequential stages in the age-dependent gradual formation and accumulation of tubular aggregates in fast twitch muscle fibers: SERCA and calsequestrin involvement","volume":"34","author":"Boncompagni","year":"2012","journal-title":"Age"},{"key":"10.1007\/s13311-014-0300-3_bib82","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","article-title":"The myotonic dystrophies: molecular, clinical, and therapeutic challenges","volume":"11","author":"Udd","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-014-0300-3_bib83","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.21948","article-title":"RNA-mediated neurodegeneration in repeat expansion disorders","volume":"67","author":"Todd","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-014-0300-3_bib84","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ceca.2008.11.005","article-title":"Alternative splicing of RyR1 alters the efficacy of skeletal EC coupling","volume":"45","author":"Kimura","year":"2009","journal-title":"Cell Calcium"},{"key":"10.1007\/s13311-014-0300-3_bib85","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/hmg\/ddi223","article-title":"Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic\/endoplasmic reticulum Ca2 + -ATPase in myotonic dystrophy type 1","volume":"14","author":"Kimura","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-014-0300-3_bib86","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/hmg\/ddr568","article-title":"Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel","volume":"21","author":"Tang","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-014-0300-3_bib87","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nm.2374","article-title":"Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy","volume":"17","author":"Fugier","year":"2011","journal-title":"Nat Med"},{"key":"10.1007\/s13311-014-0300-3_bib88","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/B978-0-08-045031-5.00002-5","article-title":"Dystrophinopathies","volume":"101","author":"Morrison","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1007\/s13311-014-0300-3_bib89","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1083\/jcb.201212142","article-title":"The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy","volume":"201","author":"Rahimov","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1007\/s13311-014-0300-3_bib90","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/333863a0","article-title":"Immunoelectron microscopic localization of dystrophin in myofibres","volume":"333","author":"Watkins","year":"1988","journal-title":"Nature"},{"key":"10.1007\/s13311-014-0300-3_bib91","doi-asserted-by":"crossref","first-page":"C1077","DOI":"10.1152\/ajpcell.00428.2009","article-title":"Excitation-contraction coupling alterations in mdx and utrophin\/dystrophin double knockout mice: a comparative study","volume":"298","author":"Capote","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1007\/s13311-014-0300-3_bib92","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nm.1916","article-title":"Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle","volume":"15","author":"Bellinger","year":"2009","journal-title":"Nat Med"},{"key":"10.1007\/s13311-014-0300-3_bib93","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1073\/pnas.0908540107","article-title":"Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy","volume":"107","author":"Fauconnier","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-014-0300-3_bib94","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1172\/JCI43844","article-title":"Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle","volume":"121","author":"Goonasekera","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-014-0300-3_bib95","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-08-045031-5.00003-7","article-title":"Sarcoglycanopathies","volume":"101","author":"Kirschner","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1007\/s13311-014-0300-3_bib96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2044-5040-2-9","article-title":"Leaky ryanodine receptors in beta-sarcoglycan deficient mice: a potential common defect in muscular dystrophy","volume":"2","author":"Andersson","year":"2012","journal-title":"Skelet Muscle"},{"key":"10.1007\/s13311-014-0300-3_bib97","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-0-08-045031-5.00007-4","article-title":"Dysferlinopathies","volume":"101","author":"Amato","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1007\/s13311-014-0300-3_bib98","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fphys.2014.00089","article-title":"Dysferlin at transverse tubules regulates Ca homeostasis in skeletal muscle","volume":"5","author":"Kerr","year":"2014","journal-title":"Front Physiol"},{"key":"10.1007\/s13311-014-0300-3_bib99","doi-asserted-by":"crossref","first-page":"20831","DOI":"10.1073\/pnas.1307960110","article-title":"Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane","volume":"110","author":"Kerr","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-014-0300-3_bib100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-08-045031-5.00006-2","article-title":"Limb-girdle muscular dystrophy 2A","volume":"101","author":"Gallardo","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1007\/s13311-014-0300-3_bib101","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1093\/hmg\/ddn223","article-title":"Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle","volume":"17","author":"Kramerova","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-014-0300-3_bib102","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00109-012-0896-x","article-title":"Selenoprotein N in skeletal muscle: from diseases to function","volume":"90","author":"Castets","year":"2012","journal-title":"J Mol Med"},{"key":"10.1007\/s13311-014-0300-3_bib103","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1089\/ars.2009.2890","article-title":"Selenoproteins and protection against oxidative stress: selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis","volume":"12","author":"Arbogast","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1007\/s13311-014-0300-3_bib104","doi-asserted-by":"crossref","first-page":"e23094","DOI":"10.1371\/journal.pone.0023094","article-title":"Increased muscle stress-sensitivity induced by selenoprotein N inactivation in mouse: a mammalian model for SEPN1-related myopathy","volume":"6","author":"Rederstorff","year":"2011","journal-title":"PloS One"},{"key":"10.1007\/s13311-014-0300-3_bib105","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/hmg\/ddq515","article-title":"Satellite cell loss and impaired muscle regeneration in selenoprotein N deficiency","volume":"20","author":"Castets","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-014-0300-3_bib106","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.spen.2011.10.005","article-title":"Core myopathies","volume":"18","author":"Jungbluth","year":"2011","journal-title":"Semin Pediatr Neurol"},{"key":"10.1007\/s13311-014-0300-3_bib107","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.1073\/pnas.0806015105","article-title":"Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle","volume":"105","author":"Jurynec","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-014-0300-3_bib108","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.21644","article-title":"Oxidative stress in SEPN1-related myopathy: from pathophysiology to treatment","volume":"65","author":"Arbogast","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-014-0300-3_bib109","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-213X-9-46","article-title":"Selenoprotein N is dynamically expressed during mouse development and detected early in muscle precursors","volume":"9","author":"Castets","year":"2009","journal-title":"BMC Develop Biol"},{"key":"10.1007\/s13311-014-0300-3_bib110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ajhg.2012.06.012","article-title":"Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores","volume":"91","author":"Majczenko","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s13311-014-0300-3_bib111","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.devcel.2013.08.021","article-title":"Deuterosome-mediated centriole biogenesis","volume":"27","author":"Klos Dehring","year":"2013","journal-title":"Develop Cell"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-014-0300-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-014-0300-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923016239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923016239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-014-0300-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:05:31Z","timestamp":1761807931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923016239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1878747923016239"],"URL":"https:\/\/doi.org\/10.1007\/s13311-014-0300-3","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triadopathies: An Emerging Class of Skeletal Muscle Diseases","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-014-0300-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}